Literature DB >> 25512093

Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies.

Kristien Peeters1, Sven Bervoets, Teodora Chamova, Ivan Litvinenko, Els De Vriendt, Stoyan Bichev, Dahlia Kancheva, Vanyo Mitev, Marina Kennerson, Vincent Timmerman, Peter De Jonghe, Ivailo Tournev, John MacMillan, Albena Jordanova.   

Abstract

The heavy chain 1 of cytoplasmic dynein (DYNC1H1) is responsible for movement of the motor complex along microtubules and recruitment of dynein components. Mutations in DYNC1H1 are associated with spinal muscular atrophy (SMA), hereditary motor and sensory neuropathy (HMSN), cortical malformations, or a combination of these. Combining linkage analysis and whole-exome sequencing, we identified a novel dominant defect in the DYNC1H1 tail domain (c.1792C>T, p.Arg598Cys) causing axonal HMSN. Mutation analysis of the tail region in 355 patients identified a de novo mutation (c.791G>T, p.Arg264Leu) in an isolated SMA patient. Her phenotype was more severe than previously described, characterized by multiple congenital contractures and delayed motor milestones, without brain malformations. The mutations in DYNC1H1 increase the interaction with its adaptor BICD2. This relates to previous studies on BICD2 mutations causing a highly similar phenotype. Our findings broaden the genetic heterogeneity and refine the clinical spectrum of DYNC1H1, and have implications for molecular diagnostics of motor neuron diseases.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  BICD2; DYNC1H1; HMSN; SMA-LED

Mesh:

Substances:

Year:  2015        PMID: 25512093     DOI: 10.1002/humu.22744

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Molecular basis for dyneinopathies reveals insight into dynein regulation and dysfunction.

Authors:  Matthew G Marzo; Jacqueline M Griswold; Kristina M Ruff; Rachel E Buchmeier; Colby P Fees; Steven M Markus
Journal:  Elife       Date:  2019-07-31       Impact factor: 8.140

2.  Combining Structure-Function and Single-Molecule Studies on Cytoplasmic Dynein.

Authors:  Lu Rao; Maren Hülsemann; Arne Gennerich
Journal:  Methods Mol Biol       Date:  2018

Review 3.  Selective motor activation in organelle transport along axons.

Authors:  Sydney E Cason; Erika L F Holzbaur
Journal:  Nat Rev Mol Cell Biol       Date:  2022-05-30       Impact factor: 113.915

4.  Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth Disease.

Authors:  Bernadett Kalmar; Amy Innes; Klaus Wanisch; Alicia Koyen Kolaszynska; Amelie Pandraud; Gavin Kelly; Andrey Y Abramov; Mary M Reilly; Giampietro Schiavo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

5.  Neurochondrin interacts with the SMN protein suggesting a novel mechanism for spinal muscular atrophy pathology.

Authors:  Luke W Thompson; Kim D Morrison; Sally L Shirran; Ewout J N Groen; Thomas H Gillingwater; Catherine H Botting; Judith E Sleeman
Journal:  J Cell Sci       Date:  2018-04-17       Impact factor: 5.285

Review 6.  Cytoplasmic dynein and its regulatory proteins in Golgi pathology in nervous system disorders.

Authors:  Dick Jaarsma; Casper C Hoogenraad
Journal:  Front Neurosci       Date:  2015-10-26       Impact factor: 4.677

Review 7.  Dominant spinal muscular atrophy is caused by mutations in BICD2, an important golgin protein.

Authors:  Lilian A Martinez-Carrera; Brunhilde Wirth
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

8.  Congenital Cataracts and Gut Dysmotility in a DYNC1H1 Dyneinopathy Patient.

Authors:  Rose Gelineau-Morel; Marshall Lukacs; K Nicole Weaver; Robert B Hufnagel; Donald L Gilbert; Rolf W Stottmann
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

9.  Identification of a de novo DYNC1H1 mutation via WES according to published guidelines.

Authors:  Dongxue Ding; Zhao Chen; Kai Li; Zhe Long; Wei Ye; Zhaoli Tang; Kun Xia; Rong Qiu; Beisha Tang; Hong Jiang
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

10.  Dynein/dynactin is necessary for anterograde transport of Mbp mRNA in oligodendrocytes and for myelination in vivo.

Authors:  Amy L Herbert; Meng-Meng Fu; Catherine M Drerup; Ryan S Gray; Breanne L Harty; Sarah D Ackerman; Thomas O'Reilly-Pol; Stephen L Johnson; Alex V Nechiporuk; Ben A Barres; Kelly R Monk
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.